The Impact of EGFR Mutation on Adjuvant Chemotherapy with UFT for Patients with Completely Resected, Non-Lymph Node Metastatic Non-Small Cell Lung Cancer (>2 cm): A Multicenter, Retrospective, Observational Study as Secondary Analysis of CSPOR-LC03 Study
Not Applicable
Recruiting
- Conditions
- Completely resected, non-lymph node metastatic non-small cell lung cancer (>2 cm)
- Registration Number
- JPRN-UMIN000047443
- Lead Sponsor
- Comprehensive Support Project for Oncology Research (CSPOR), Public Health Research Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 2599
Inclusion Criteria
Not provided
Exclusion Criteria
Patients whose status of use of adjuvant chemotherapy is unknown.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 5-year recurrence-free survival (RFS) rate
- Secondary Outcome Measures
Name Time Method 5-year overall survival (OS) rate